TSCAN THERAPEUTICS, INC. Earnings Per Share (Diluted)
TSCAN THERAPEUTICS, INC. (TCRX) reported Earnings Per Share (Diluted) of -$0.23 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-12
- TSCAN THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.23.
- TSCAN THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.22.
- TSCAN THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2025-12-31 was -$0.18.
- TSCAN THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.28.
- TSCAN THERAPEUTICS, INC. earnings per share, diluted for fiscal 2025 was -$1.00.
- TSCAN THERAPEUTICS, INC. earnings per share, diluted for fiscal 2024 was -$1.14.
- TSCAN THERAPEUTICS, INC. earnings per share, diluted for fiscal 2023 was -$1.36.
- TSCAN THERAPEUTICS, INC. earnings per share, diluted for fiscal 2022 was -$2.75.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.23 10-Q · filed 2026-08-12 | -$0.45 10-Q · filed 2026-08-12 | -$0.63 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.91 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2026-03-31 | -$0.22 10-Q · filed 2026-05-06 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-05-06 | -$0.67 derived: net income ÷ weighted average shares · filed 2026-05-06 | -$0.96 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-12-31 | -$0.18 derived: net income ÷ weighted average shares · filed 2026-03-04 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-03-04 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.00 10-K · filed 2026-03-04 |
| 2025-09-30 | -$0.28 10-Q · filed 2025-11-12 | -$0.56 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.82 10-Q · filed 2025-11-12 | -$1.12 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-06-30 | -$0.28 10-Q · filed 2026-08-12 | -$0.55 10-Q · filed 2026-08-12 | -$0.84 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.10 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-03-31 | -$0.26 10-Q · filed 2026-05-06 | -$0.56 derived: net income ÷ weighted average shares · filed 2026-05-06 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-05-06 | -$1.09 derived: net income ÷ weighted average shares · filed 2026-05-06 |
| 2024-12-31 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-03-04 | -$0.55 derived: net income ÷ weighted average shares · filed 2026-03-04 | -$0.83 derived: net income ÷ weighted average shares · filed 2026-03-04 | -$1.14 10-K · filed 2026-03-04 |
| 2024-09-30 | -$0.25 10-Q · filed 2025-11-12 | -$0.53 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.84 10-Q · filed 2025-11-12 | -$1.05 derived: net income ÷ weighted average shares · filed 2025-11-12 |
| 2024-06-30 | -$0.28 10-Q · filed 2025-08-12 | -$0.59 10-Q · filed 2025-08-12 | -$0.80 derived: net income ÷ weighted average shares · filed 2025-08-12 | -$1.05 derived: net income ÷ weighted average shares · filed 2025-08-12 |
| 2024-03-31 | -$0.32 10-Q · filed 2025-05-06 | -$0.52 derived: net income ÷ weighted average shares · filed 2025-05-06 | -$0.77 derived: net income ÷ weighted average shares · filed 2025-05-06 | -$1.17 derived: net income ÷ weighted average shares · filed 2025-05-06 |
| 2023-12-31 | -$0.21 derived: net income ÷ weighted average shares · filed 2025-03-05 | -$0.45 derived: net income ÷ weighted average shares · filed 2025-03-05 | -$0.84 derived: net income ÷ weighted average shares · filed 2025-03-05 | -$1.36 10-K · filed 2025-03-05 |
| 2023-09-30 | -$0.24 10-Q · filed 2024-11-12 | -$0.66 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.25 10-Q · filed 2024-11-12 | -$1.86 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2023-06-30 | -$0.51 10-Q · filed 2024-08-12 | -$1.30 10-Q · filed 2024-08-12 | -$2.05 derived: net income ÷ weighted average shares · filed 2024-08-12 | -$2.73 derived: net income ÷ weighted average shares · filed 2024-08-12 |
| 2023-03-31 | -$0.93 10-Q · filed 2024-05-13 | -$1.71 derived: net income ÷ weighted average shares · filed 2024-05-13 | -$2.38 derived: net income ÷ weighted average shares · filed 2024-05-13 | -$3.01 derived: net income ÷ weighted average shares · filed 2024-05-13 |
| 2022-12-31 | -$0.78 derived: net income ÷ weighted average shares · filed 2024-03-06 | -$1.45 derived: net income ÷ weighted average shares · filed 2024-03-06 | -$2.08 derived: net income ÷ weighted average shares · filed 2024-03-06 | -$2.75 10-K · filed 2024-03-06 |
| 2022-09-30 | -$0.67 10-Q · filed 2023-11-09 | -$1.30 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.98 10-Q · filed 2023-11-09 | -$2.57 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-06-30 | -$0.63 10-Q · filed 2023-08-10 | -$1.30 10-Q · filed 2023-08-10 | -$1.89 derived: net income ÷ weighted average shares · filed 2023-08-10 | -$2.67 derived: net income ÷ weighted average shares · filed 2023-08-10 |
| 2022-03-31 | -$0.67 10-Q · filed 2023-05-10 | -$1.27 derived: net income ÷ weighted average shares · filed 2023-05-10 | -$2.04 derived: net income ÷ weighted average shares · filed 2023-05-10 | -$3.29 derived: net income ÷ weighted average shares · filed 2023-05-10 |
| 2021-12-31 | -$0.59 derived: net income ÷ weighted average shares · filed 2023-03-08 | -$1.37 derived: net income ÷ weighted average shares · filed 2023-03-08 | -$2.70 derived: net income ÷ weighted average shares · filed 2023-03-08 | -$4.17 10-K · filed 2023-03-08 |
| 2021-09-30 | -$0.80 10-Q · filed 2022-11-09 | -$2.49 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$4.55 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$7.69 10-Q · filed 2022-08-10 | -$14.25 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B |